F-THK5351 PET Can Evaluate Tumor Extension in Intravascular Large B-Cell Lymphoma: Comparison with 11C-Methionine PET and 18F-FDG PET
Clinical Nuclear Medicine, ISSN: 1536-0229, Vol: 48, Issue: 4, Page: E204-E206
2023
- 6Citations
- 1Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations6
- Citation Indexes6
- CrossRef3
- Captures1
- Readers1
- Mentions2
- News Mentions2
- News2
Most Recent News
Findings from Department of Neurology Update Understanding of B-Cell Lymphoma (F-18-thk5351 Pet Can Evaluate Tumor Extension In Intravascular Large B-cell Lymphoma Comparison With C-11-methionine Pet and F-18-fdg Pet)
2023 APR 18 (NewsRx) -- By a News Reporter-Staff News Editor at NewsRx Hematology Daily -- Fresh data on Oncology - B-Cell Lymphoma are presented
Article Description
A 79-year-old man presenting with gait disturbance and cognitive decline was diagnosed with intravascular large B-cell lymphoma (IVLBCL) by random skin biopsy. Some IVLBCL lesions were identified by PET examinations using 11C-methionine, 18F-FDG, and 18F-THK5351. 11C-methionine and 18F-FDG uptake, which likely reflects the presence of the lymphoma cells themselves, increased clearly in the left putamen but weakly in the left deep white matter. 18F-THK5351 uptake increased in all lesions, likely reflecting perivascular astrogliosis caused by IVLBCL. Hence, 18F-THK5351 PET can evaluate tumor extension in IVLBCL lesions where 11C-methionine and 18F-FDG PET may fail in its visualization.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85149167370&origin=inward; http://dx.doi.org/10.1097/rlu.0000000000004568; http://www.ncbi.nlm.nih.gov/pubmed/36727871; https://journals.lww.com/10.1097/RLU.0000000000004568; https://dx.doi.org/10.1097/rlu.0000000000004568; https://journals.lww.com/nuclearmed/abstract/2023/04000/18f_thk5351_pet_can_evaluate_tumor_extension_in.49.aspx
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know